Telehealth model to improve treatment access for rural veterans with substance use disorders
Using Telehealth to Expand Treatment Access for Veterans With Opioid Use Disorder (CDA 18-008)
NA · VA Office of Research and Development · NCT05348317
This study is testing a new telehealth program to help veterans with substance use disorders get better access to treatment and support, especially those living in rural areas.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | VA Office of Research and Development (fed) |
| Locations | 1 site (Ann Arbor, Michigan) |
| Trial ID | NCT05348317 on ClinicalTrials.gov |
What this trial studies
This project aims to pilot-test a telehealth-delivered care model for veterans with substance use disorders (SUDs), focusing on increasing treatment utilization and improving outcomes. The approach involves initial engagement and ongoing motivational interviewing and cognitive behavioral therapy (MI-CBT) delivered remotely. Stakeholder input will be gathered to refine the model and ensure it meets the needs of both rural and non-rural veterans. The study will take place at the Ann Arbor VA Healthcare System.
Who should consider this trial
Good fit: Ideal candidates for this study are veterans diagnosed with substance use disorders who have access to a telephone and can provide informed consent.
Not a fit: Patients currently receiving SUD psychotherapy or those with substantial mental health instability may not benefit from this study.
Why it matters
Potential benefit: If successful, this model could significantly enhance access to treatment for veterans with substance use disorders, particularly in rural areas.
How similar studies have performed: Other studies have shown promise in using telehealth for substance use treatment, indicating that this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Veteran patients at the Ann Arbor VA Healthcare System * Diagnostic and Statistical Manual of Mental Disorders (DSM-5) SUD diagnosis and/or substance use on average of 2 days a week over the past month * Telephone access * Able to provide informed consent Exclusion Criteria: * Receiving SUD psychotherapy * Inability to speak or understand English * Substantial mental health instability or conditions that preclude informed consent (e.g., acute psychosis, cognitive deficits) or understanding of assessment or program content * Prior alcohol withdrawal seizures or delirium tremens
Where this trial is running
Ann Arbor, Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI — Ann Arbor, Michigan, United States (RECRUITING)
Study contacts
- Principal investigator: Lewei Lin, MD — VA Ann Arbor Healthcare System, Ann Arbor, MI
- Study coordinator: Deborah A Manderachia, MSW
- Email: deborah.manderachia@va.gov
- Phone: (734) 222-7424
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Substance Use, Substance Use Disorders, Substance Dependence, Veterans, Telehealth, Motivational Interviewing, Cognitive Behavioral Therapy, Rural Health